Medfinder
Back to blog

Updated: January 26, 2026

How Does Arimidex Work? Mechanism of Action Explained in Plain English

Author

Peter Daggett

Peter Daggett

Body silhouette with glowing pathways showing drug mechanism of action

How does Arimidex (anastrozole) actually stop breast cancer? Here's a plain-English explanation of the mechanism of action of this aromatase inhibitor.

Understanding how Arimidex works doesn't require a medical degree. With a basic grasp of what estrogen does and how it relates to breast cancer, the mechanism of anastrozole becomes intuitive — and understanding it can help you appreciate why the medication is effective and why it causes the side effects it does.

Step 1: The Role of Estrogen in Hormone Receptor-Positive Breast Cancer

About 70-80% of all breast cancers are hormone receptor-positive, meaning the cancer cells have proteins (receptors) on their surface that bind to estrogen and progesterone. When estrogen binds to these receptors, it acts like a key turning on a growth signal — telling the cancer cell to divide and multiply.

In premenopausal women, estrogen is primarily made by the ovaries. After menopause, the ovaries stop producing estrogen — but the body doesn't stop making it entirely. Instead, estrogen production shifts to peripheral tissues: fat cells, muscle, and the adrenal glands. These tissues convert androgens (like androstenedione and testosterone) into estrogen using an enzyme called aromatase.

Step 2: What Is the Aromatase Enzyme?

Aromatase (technically CYP19A1) is a protein found in fat tissue, muscle, liver, skin, and even in breast cancer tissue itself. Its job is to convert male hormones (androgens) into estrogen — specifically estrone and estradiol — through a chemical process called aromatization.

In postmenopausal women, this aromatase-driven conversion in peripheral tissues becomes the primary source of estrogen. This is important because it means estrogen is still being made and still able to drive cancer growth — even after menopause.

Step 3: How Anastrozole Blocks the Process

Anastrozole is a selective, non-steroidal aromatase inhibitor. "Selective" means it specifically targets aromatase without significantly interfering with other enzymes. "Non-steroidal" refers to its chemical structure — it's not derived from a steroid molecule.

Anastrozole works by competitively binding to the aromatase enzyme — essentially sitting in the enzyme's active site and blocking it from doing its job. Without aromatase activity, the conversion of androgens to estrogen cannot occur. The result is a dramatic drop in circulating estrogen levels.

Specifically, a single 1 mg dose of anastrozole reduces serum estradiol by approximately 70% within 24 hours. After 14 days of daily dosing, estradiol is suppressed by approximately 80%, reaching the lower limit of detection of standard assays (below 3.7 pmol/L). This level of suppression is maintained throughout treatment.

Step 4: Why Does This Stop Cancer Growth?

Without estrogen to bind to their receptors, hormone receptor-positive cancer cells lose one of their primary growth signals. The cancer cells can no longer receive the "divide" signal from estrogen. This is why anastrozole is described as slowing or stopping tumor growth, and in the adjuvant (post-surgery) setting, why it significantly reduces the risk of cancer recurrence.

Importantly, anastrozole does not directly kill cancer cells the way chemotherapy does. Instead, it deprives hormone receptor-positive cancer cells of the fuel they need to grow. This is why it's used for years rather than months — it's an ongoing suppression strategy, not a one-time attack.

What Anastrozole Does NOT Affect

Anastrozole's selectivity means it has some important boundaries:

  • It has no detectable effect on adrenal corticosteroid production (aldosterone, cortisol) — so patients don't experience adrenal insufficiency
  • It does not significantly inhibit CYP450 enzymes responsible for metabolizing many other drugs (P450 2A6, 2D6), making it relatively low-risk for drug-drug interactions related to drug metabolism
  • It does not work in premenopausal women with functional ovaries, because the ovaries produce estrogen through a different pathway that anastrozole doesn't block

Why the Mechanism Explains the Side Effects

Once you understand that anastrozole works by dramatically reducing estrogen levels, many of its side effects make sense:

  • Hot flashes — estrogen normally helps regulate body temperature
  • Joint and bone pain — estrogen helps maintain joint lubrication and bone density
  • Bone loss — estrogen is critical for maintaining bone mineral density; without it, bones become more porous over time
  • Vaginal dryness — estrogen maintains vaginal tissue health and lubrication
  • Cholesterol changes — estrogen influences lipid metabolism, so lower estrogen can raise LDL cholesterol

Anastrozole vs. Tamoxifen: Different Mechanisms

Tamoxifen is often confused with aromatase inhibitors, but it works completely differently. Tamoxifen is a selective estrogen receptor modulator (SERM) — it doesn't prevent estrogen from being made. Instead, it blocks the estrogen receptor in breast tissue, preventing estrogen from binding there. Anastrozole takes the opposite approach: it prevents estrogen from being made in the first place.

This is why the two drugs cannot and should not be taken together: combining them provides no additional benefit (and tamoxifen actually reduces anastrozole blood levels by 27%).

Bottom Line

Anastrozole works by blocking the aromatase enzyme, which stops the conversion of androgens into estrogen in peripheral tissues. This dramatically reduces estrogen levels (by approximately 80% at steady state), depriving hormone receptor-positive breast cancer cells of the growth signal they need. The same mechanism explains its side effects — all essentially symptoms of low estrogen. For more on what this means day-to-day, read our articles on Arimidex side effects and Arimidex drug interactions.

Frequently Asked Questions

Anastrozole blocks the aromatase enzyme, which prevents the body from converting androgens into estrogen in peripheral tissues (fat, muscle, liver). By reducing estrogen levels by approximately 80%, anastrozole deprives hormone receptor-positive breast cancer cells of the estrogen they need to grow and divide.

Anastrozole 1 mg reduces serum estradiol by approximately 70% within 24 hours of the first dose. After 14 days of daily dosing, estradiol suppression reaches approximately 80%, bringing levels to the lower limit of detection. This suppression is maintained throughout treatment.

In premenopausal women, the majority of estrogen is produced directly by the ovaries through a different pathway that anastrozole doesn't block. Anastrozole only blocks the peripheral conversion of androgens to estrogen (via aromatase). For premenopausal women, ovarian suppression would be needed alongside or instead of an aromatase inhibitor.

No. Arimidex (anastrozole) and tamoxifen are two entirely different types of drugs that work through different mechanisms. Anastrozole prevents estrogen from being made by blocking the aromatase enzyme. Tamoxifen blocks the estrogen receptor so estrogen can't bind to it. The two should never be taken together — they are contraindicated as a combination.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Arimidex also looked for:

36,651 have already found their meds with Medfinder.

Start your search today.

36K+
5-star ratingTrusted by 36,651 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?